We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
-25.08%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$463M
AUM Growth
-$122M
(-21%)
Cap. Flow
+$51.3M
Cap. Flow
% of AUM
11.09%
Top 10 Holdings %
Top 10 Hldgs %
9.68%
Holding
1,051
New
472
Increased
169
Reduced
110
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$13.6M |
| 2 |
Occidental Petroleum
OXY
|
+$6.95M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$6.41M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$4.25M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$4.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.5M |
| 2 |
Verizon
VZ
|
+$6.68M |
| 3 |
Target
TGT
|
+$6.64M |
| 4 |
Roku
ROKU
|
+$6.35M |
| 5 |
Walmart Inc
WMT
|
+$5.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.02% |
| 2 | Healthcare | 14.77% |
| 3 | Consumer Discretionary | 13.92% |
| 4 | Industrials | 9.71% |
| 5 | Consumer Staples | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Boston Scientific
BSX
$67.6B
| $1.13M | 0.24% |
34,600
+20,700
| +149% | +$809K |
|
102
West Pharmaceutical
WST
$24.4B
| $1.12M | 0.24% |
7,373
-1,972
| -21% | -$304K |
|
103
Welltower
WELL
$173B
| $1.12M | 0.24% |
+24,445
| New | +$1.8M |
|
104
Charles River Laboratories
CRL
$14.2B
| $1.11M | 0.24% |
+8,800
| New | +$1.32M |
|
105
Dynatrace
DT
$15.4B
| $1.11M | 0.24% |
+46,482
| New | +$1.34M |
|
106
iShares Core S&P Small-Cap ETF
IJR
$111B
| $1.1M | 0.24% |
+19,700
| New | +$1.47M |
|
107
UnitedHealth
UNH
$355B
| $1.1M | 0.24% |
+4,400
| New | +$1.21M |
|
|
RP
108
DELISTED
RealPage, Inc.
RP
| $1.1M | 0.24% |
+20,712
| New | +$1.18M |
|
109
Adobe
ADBE
$115B
| $1.09M | 0.24% |
3,436
-6,654
| -66% | -$2.28M |
|
110
AbbVie
ABBV
$456B
| $1.08M | 0.23% |
14,207
-6,893
| -33% | -$587K |
|
111
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
| $1.08M | 0.23% |
4,912
+942
| +24% | +$250K |
|
112
Dover
DOV
$27.2B
| $1.08M | 0.23% |
12,829
+9,995
| +353% | +$1.06M |
|
113
Colgate-Palmolive
CL
$72.5B
| $1.07M | 0.23% |
+16,200
| New | +$1.14M |
|
114
Trip.com Group
TCOM
$28.1B
| $1.07M | 0.23% |
+45,781
| New | +$1.43M |
|
115
iShares MSCI USA Min Vol Factor ETF
USMV
$24.5B
| $1.07M | 0.23% |
+19,800
| New | +$1.26M |
|
116
Quanta Services
PWR
$93.5B
| $1.07M | 0.23% |
+33,600
| New | +$1.25M |
|
117
Williams Companies
WMB
$90.7B
| $1.06M | 0.23% |
74,996
+14,796
| +25% | +$287K |
|
118
Alcoa
AA
$13.5B
| $1.06M | 0.23% |
+171,700
| New | +$2.36M |
|
119
GameStop
GME
$8.19B
| $1.06M | 0.23% |
+1,206,800
| New | +$1.29M |
|
120
Applied Materials
AMAT
$383B
| $1.05M | 0.23% |
23,000
+18,300
| +389% | +$1.05M |
|
|
GOOS
121
Canada Goose Holdings
GOOS
$791M
| $1.05M | 0.23% |
52,700
+41,500
| +371% | +$1.16M |
|
|
ALXN
122
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.05M | 0.23% |
11,646
+8,146
| +233% | +$799K |
|
|
SKX
123
DELISTED
Skechers
SKX
| $1.04M | 0.23% |
44,038
+23,000
| +109% | +$793K |
|
124
Morgan Stanley
MS
$337B
| $1.04M | 0.22% |
30,604
+26,604
| +665% | +$1.25M |
|
|
AXON
125
Axon Enterprise
AXON
$49.7B
| $1.03M | 0.22% |
+14,625
| New | +$1.09M |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Bayesian Capital Management held 1,051 positions worth $463M, down 21% from $585M the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Bayesian Capital Management deployed $51.3M of net new capital in Q1 2020, opening 472 new positions and adding to 169 existing holdings. Its largest new stake was Occidental Petroleum: 211,482 shares worth $2.45M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Target, an estimated $6.64M trimmed.
- Bayesian Capital Management's largest Q1 2020 buy was Occidental Petroleum: 211,482 shares worth $2.45M.
- Bayesian Capital Management added most to Walgreens Boots Alliance in Q1 2020, an estimated $13.6M increase.
- Bayesian Capital Management's biggest Q1 2020 reduction was Target, cutting an estimated $6.64M.
- Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2020, selling an estimated $35.5M.
- Bayesian Capital Management's ten largest holdings make up 9.7% of its $463M portfolio in Q1 2020.
- Bayesian Capital Management opened 472 new positions and closed 299 in Q1 2020.
- Bayesian Capital Management's portfolio value fell 21% quarter-over-quarter to $463M.
Based on Bayesian Capital Management's 13F filing for Q1 2020, filed 15 May 2020.